Table 1.
Baseline Characteristics Associated with Azithromycin Prescriptions
| Characteristic | Pre-intervention (N = 306) | Post-intervention (N = 263) |
|---|---|---|
| Age (years), mean (SD) | 57.0 (12.0) | 48.0 (8.5) |
| Female, n (%) | 223 (72.9) | 182 (69.2) |
| Race, n (%) | ||
| Black | 235 (76.8) | 174 (66.2) |
| White | 30 (9.8) | 31 (11.8) |
| Hispanic | 21 (6.9) | 32 (12.1) |
| Other | 20 (6.5) | 26 (9.9) |
| Duration of therapy (days), median (IQR) | 5 (5.5) | 5 (5.5) |
| Provider, n (%) | ||
| Attending physician | 222 (72.5) | 196 (74.5) |
| Resident physician | 66 (21.6) | 40 (15.2) |
| Advanced practice provider | 18 (5.9) | 27 (10.3) |
| Clinic type, n (%) | ||
| Non-academic | 218 (71.2) | 200 (76.0) |
| Academic | 88 (28.8) | 63 (24.0) |
| Indication, inappropriate/total prescriptions (% inappropriate) | ||
| Bronchitis | 75/77 (97.4) | 69/69 (100) |
| URI, unspecified | 108/110 (98.2) | 61/62 (98.4) |
| Pneumonia | 0/28 (0) | 1/37 (2.7) |
| COPD exacerbation | 11/28 (39.3) | 15/32 (46.9) |
| Sinusitis | 37/38 (97.4) | 17/17 (100) |
| COPD, chronic | 0/5 (0) | 0/10 (0) |
| Asthma exacerbation | 12/13 (92.3) | 5/5 (100) |
| Otitis media | 0/2 (0) | 1/5 (20) |
| Pharyngitis | 5/5 (100) | 4/4 (100) |
| Bronchiolitis | 0/3 (0) | 0/3 (0) |
| Lymphadenopathy | 0/0 (0) | 3/3 (100) |
| Traveler’s diarrhea | 0/0 (0) | 0/3 (0) |
| Other | 3/3 (100) | 5/11 (45.5) |
URI, upper respiratory tract infection; COPD, chronic obstructive pulmonary disorder